Publication | Closed Access

Infliximab counteracts tumor necrosis factor-α-enhanced induction of matrix metalloproteinases that degrade claudin and occludin in non-pigmented ciliary epithelium

Factor-α-enhanced InductionImmune RegulationImmunologyPathologyTumor BiologyInflammationNon-pigmented Ciliary EpitheliumMatrix MetalloproteinasesCell SignalingChronic InflammationImmune SurveillanceVascular BiologyInflammatory DiseaseCell BiologyCytokineAnti-inflammatoryCell-matrix InteractionMedicineExtracellular Matrix